 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Watchers	4,141
52-Wk Low	$0.12
52-Wk High	$1.15

Market Cap	$54.76M
Volume (M)	6,672.00
52-Wk High	$1.15
52-Wk Low	$0.12

NYMXF Nymox Pharmaceutical Corp

About

Feed

News

Sentiment

Fundamentals